Sunovion Pharmaceuticals Inc.Marlborough, MA United States
Company Description
Helping people breathe easy and sleep properly are the core of Sunovion (formerly Sepracor). The company focuses its drug development efforts in two main therapeutic categories: respiratory and central nervous system (CNS) disorders. Among its six marketed products are asthma drug Xopenex, insomnia therapy Lunesta, and chronic obstructive pulmonary disease (COPD) treatment Brovana. Sunovion markets its products to primary care physicians and some specialists in the US. It has licensed international development and commercialization rights for Lunesta to
| 84 Waterford Dr. | Phone: 508-481-6700 | http://www.sunovion.com |
| Marlborough, MA 01752 | Fax: 508-357-7499 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Sunovion Pharmaceuticals Inc. Rankings
Executives
| 91 executives listed for Sunovion Pharmaceuticals Inc.'s Marlborough, MA location. | ||
| Chairman and CEO | Saburo Hamanaka | |
|---|---|---|
| President, COO, and Director | Mark Iwicki | |
Financials
| Company Type | SubsidiaryHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 2,400 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Sunovion Pharmaceuticals Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
